IHS Chemical Week

Regions :: Western Europe :: U.K.

'Patent Box' Legislation Attracts GSK to Invest $776 Million in U.K.

9:03 AM MST | November 30, 2010 | Alex Scott

Legislation proposed this week by the U.K. government to encourage the development of intellectual property (IP) and manufacturing in the U.K. has led GlaxoSmithKline (GSK) to announce a £500 million ($776 million) investment in R&D and manufacturing in the country.   GSK’s package of planned investments features a £50 million U.K. venture capital fund for early stage healthcare companies and university spin outs; formation of a green chemistry academy at the University of Nottingham (Nottingham, U.K.); additional investment in...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa